Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
McCarthy PM, Valdera FA, Smolinsky TR, Adams AM, O'Shea AE, Thomas KK, Van Decar S, Carpenter EL, Tiwari A, Myers JW, Hale DF, Vreeland TJ, Peoples GE, Stojadinovic A, Clifton GT.
McCarthy PM, et al. Among authors: o shea ae.
Front Immunol. 2023 Mar 7;14:1090533. doi: 10.3389/fimmu.2023.1090533. eCollection 2023.
Front Immunol. 2023.
PMID: 36960052
Free PMC article.